Project Grant 2332861
Award Date
5/1/24
Completion Date
4/30/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
Dencoda LLC (J1W3J87E5MN4)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is providing $275,000 to Dinya DNA Inc. to support the commercial development of a novel DNA synthesis technology. The key products or services being delivered include: Developing new methods to ensure higher fidelity DNA precursors, which are the building blocks for DNA synthesis Reducing synthesis costs by streamlining the DNA synthesis reactions...
This National Science Foundation (NSF) SBIR Phase I award to Foragr Medicines, Inc. provides $275,000 to develop a high-throughput platform for small molecule targeting of undruggable proteins via their mRNAs. The project aims to create an efficient and cost-effective approach to discover new therapeutics for previously untreatable diseases, including neurodegenerative conditions and aggressive cancers. Key innovations include automating ligand screening against mRNA targets and enabling...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,932 to Femtofluidics Incorporated aims to develop hardware that can rapidly and inexpensively synthesize DNA-encoded libraries (DELs) for accelerating drug discovery. The proposed device will use electronics to manipulate nanoliter to picoliter volume droplets, eliminating the need for liquid-handling robots with mechanical parts. This technology could expedite finding...
This award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $303,864 to Core Biotherapeutics Inc., a for-profit organization, to develop a platform for designing disruptive drug candidates that can address high unmet medical needs. The project aims to determine the biological laws governing molecular networks that drive diseases and program these into an efficient, scalable algorithm for drug target discovery. This...
This Project Grant award from the National Cancer Institute's Cancer Biology Research Federal Grant Program (CFDA 93.396) is focused on developing activity-based sensor peptides for quantitating oncogenic protein kinases in cell and tissue samples. The key products to be delivered under this $1,093,104 award from August 2024 to July 2026 include: Commercialization of lysate-compatible sensor peptides for the MAPK kinases ERK1/2, based on the Phase 1 product AQT0491, as well as sensor peptides...
This $274,991 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a new approach to deliver cancer-killing proteins specifically to acute myeloid leukemia (AML) cells while sparing healthy cells. The project aims to engineer natural killer (NK) cells with targeted protein degraders (TPDs) against three common AML driver proteins, with the goal of demonstrating...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $275,000 will support the development of a plasmonic nanopore sensor device for quality control of adeno-associated viruses (AAVs) used in gene therapy. The proposed device will enable accurate characterization of AAV payload (single-stranded DNA, double-stranded DNA, or empty) at low, pre-scale-up concentrations to optimize formulations. The project aims to demonstrate the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $331,189 to the University of Central Florida (UCF) aims to develop an affordable, portable platform for virus detection in resource-limited environments. The project integrates protein engineering and electrochemical biosensor technologies to create a single-temperature, nucleic acid sequence-based amplification technique for virus detection. Key innovations include the use of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,362 provides funding to RT Microdx Inc., a minority-owned small business, to develop a novel molecular diagnostic platform for detecting respiratory diseases like strep throat. The platform aims to enable rapid, reliable, and affordable at-home pathogen detection without requiring an expensive tabletop device. The anticipated technical outcomes include a disposable,...